A carregar...

Assessment of the Potential of CDK2 Inhibitor NU6140 to Influence the Expression of Pluripotency Markers NANOG, OCT4, and SOX2 in 2102Ep and H9 Cells

As cyclin-dependent kinases (CDKs) regulate cell cycle progression and RNA transcription, CDKs are attractive targets for creating cancer cell treatments. In this study we investigated the effects of the small molecular agent NU6140 (inhibits CDK2 and cyclin A interaction) on human embryonic stem (h...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Cell Biol
Main Authors: Kallas, Ade, Pook, Martin, Trei, Annika, Maimets, Toivo
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4248398/
https://ncbi.nlm.nih.gov/pubmed/25477962
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/280638
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!